Champions Oncology Inc Receivables Turnover Ratio (CSBR), from the first quarter 2026 to the first quarter 2026 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Champions Oncology Inc   (NASDAQ: CSBR)
 

Champions Oncology Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2026

Quarterly Results, Trends, Rankings, Statistics


Champions Oncology Inc 's ability to collect accounts receivable sequentially worsen to 3.72, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Champions Oncology Inc 's Accounts Receivable average collection period in the Jul 31 2026 quarter, has increased to 98 days, from 81 days, in the Apr 30 2026 quarter.

If we take a look into Healthcare sector 417 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jul 31 2026 from 2426 to 2827.

What is Receivable Turnover Ratio?
What is Champions Oncology Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSBR Receivables Turnover Ratio (Jul 31 2026)
I. Quarter		 (Apr 30 2026)
IV. Quarter		 (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter
Y / Y Receivable Change 130.38 % 84.32 % 17.93 % 10.21 % 4.89 %
Y / Y Revenue Change 8.84 % 11.99 % -2.82 % 11.46 % -0.47 %
Receivable Turnover Ratio (TTM) 3.72 4.49 5.33 5.59 5.59
CSBR's Total Ranking # 2827 # 2426 # 2466 # 2513 # 2716
Accounts Receivable average collection period days 98 81 68 65 65
Seq. Receivable Change 5.41 % 84.32 % -2.64 % 21.8 % -15.67 %
Seq. Revenue Change 10.09 % -16.44 % 10.14 % 7.43 % 13.27 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 418
Overall Market # 2827

Receivable Turnover Ratio Statistics
High Average Low
14.17 7.31 4.9
(Apr 30 2013)   (Jul 31 2026)





CSBR Company Profile • Back to CSBR Efficiency Comparisons • Compare CSBR Receivables Turnover Ratio to its Competitors

Financial Statements
Champions Oncology Inc 's Accounts Receivable $ 22 Millions Visit CSBR's Balance sheet
Champions Oncology Inc 's Sales TTM $ 61 Millions Visit CSBR's Income Statement
Sources of CSBR's Revenues Visit CSBR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CSBR's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CSBR's Growth Rates CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Dividend Comparisons
CSBR's Profitability Ratios CSBR's Roi CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Valuation Ratios CSBR's Roe CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jul 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jul 31 2026 Receivable at quarter ending Jul 31 2026
Novocure Limited  7.62 $ 699.193  Millions$ 91.768  Millions
Natera Inc   7.61 $ 2,707.077  Millions$ 355.618  Millions
Co diagnostics Inc   7.58 $ 0.721  Millions$ 0.095  Millions
Quest Diagnostics Inc  7.56 $ 11,560.000  Millions$ 1,529.250  Millions
Edap Tms Sa  7.55 $ 111.051  Millions$ 14.699  Millions
Fortress Biotech Inc   7.55 $ 69.983  Millions$ 9.266  Millions
Protalix Biotherapeutics inc   7.55 $ 80.619  Millions$ 10.677  Millions
Pmgc Holdings Inc   7.55 $ 2.579  Millions$ 0.342  Millions
Solventum Corporation  7.52 $ 8,310.000  Millions$ 1,105.500  Millions
Iridex Corp  7.49 $ 51.044  Millions$ 6.816  Millions
Merit Medical Systems Inc  7.48 $ 1,579.403  Millions$ 211.171  Millions
Intuitive Surgical Inc   7.46 $ 11,296.300  Millions$ 1,513.950  Millions
Transmedics Group Inc   7.43 $ 668.468  Millions$ 89.962  Millions
Seres Therapeutics Inc   7.42 $ 1.883  Millions$ 0.254  Millions
Blue Water Vaccines Inc  7.41 $ 0.646  Millions$ 0.087  Millions
Renovorx Inc   7.40 $ 1.976  Millions$ 0.267  Millions
Maravai Lifesciences Holdings Inc   7.39 $ 207.886  Millions$ 28.147  Millions
Nurix Therapeutics Inc   7.35 $ 36.766  Millions$ 5.000  Millions
Cerus Corporation  7.35 $ 221.224  Millions$ 30.111  Millions
Anteris Technologies Global Corp   7.34 $ 2.242  Millions$ 0.305  Millions
Palatin Technologies Inc   7.34 $ 13.185  Millions$ 1.797  Millions
Lucid Diagnostics Inc   7.33 $ 5.445  Millions$ 0.742  Millions
Foxo Technologies Inc   7.27 $ 24.846  Millions$ 3.420  Millions
Si bone inc   7.23 $ 214.331  Millions$ 29.648  Millions
Insmed Inc  7.18 $ 1,076.572  Millions$ 149.999  Millions
Rhythm Pharmaceuticals Inc   7.18 $ 239.918  Millions$ 33.429  Millions
Omada Health Inc   7.15 $ 308.445  Millions$ 43.147  Millions
Travere Therapeutics Inc   7.14 $ 591.330  Millions$ 82.764  Millions
Pulmonx Corporation  7.14 $ 87.393  Millions$ 12.237  Millions
Twist Bioscience Corporation  7.10 $ 431.798  Millions$ 60.812  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.